Long-COVID vs. POTS: Characterization of the Patient Experience

Summary

Long-COVID is a condition marked by the continuation of COVID-19 symptoms—or the emergence of new ones—after recovery from acute (or the initial phase of illness of) COVID-19. While there is not yet a formal definition of long COVID, it generally refers to the persistence of symptoms four weeks or longer after the onset of COVID-19. Long-COVID has many similarities to disorders of the autonomic nervous system, such as postural orthostatic tachycardia syndrome (POTS).

In this study we are trying to understand the quality of life of Long-COVID and POTS patients.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 18 to 80

Inclusion criteria:

• Patients with Long-COVID:
o Long-COVID symptoms for at least 3 months after COVID infection

• Patients with POTS
o Physician Diagnosis of POTS as defined by the CCS Consensus Statement1 and as follows:
 Sustained, excessive orthostatic tachycardia ≥ 30 bpm within 10 minutes standing.
 Absence of orthostatic hypotension (>20/10 mmHg decrease) within 3 minutes standing

• Canadian resident
• Age 18-80 years
• Male and female
• Able and willing to provide informed consent

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Rashmin Hira

Principal investigator:

Satish Raj

Clinical trial:

No

REB-ID:

REB22-0724